LEADER 2: baseline calcitonin in 9340 people with type 2...

Diabetes, Obesity and Metabolism 2015 / 05 Vol. 17; Iss. 5

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Daniels, G. H., Hegedüs, L., Marso, S. P., Nauck, M. A., Zinman, B., Bergenstal, R. M., Mann, J. F. E., Derving Karsbøl, J., Moses, A. C., Buse, J. B., Tuttle, R. M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12444
Date:
May, 2015
File:
PDF, 980 KB
english, 2015
Conversion to is in progress
Conversion to is failed